The second edition of the Psychedelic Therapeutics and Drug Development Conference took place in Washington DC from May 23-24, 2022. This event highlighted the progress being made towards regulatory approval of various psychedelics with the potential to treat various conditions, including inflammatory/autoimmune disorders, brain injury, pain, PTSD, anxiety, ADHD, headaches, depression, and opioid use disorder.
Find out more about Psychedelic Therapeutics and Drug Development Conference
Type of Event: Conference
Audience: Academic
Dates: 23 - 24 May 2022